Conference Chair
William Schmidt, Ph.D.
President
Northstar Consulting
Speaking Faculty
-
Laura Bohn, Ph.D.
- Professor, Departments of Molecular Medicine & Neuroscience
- The Scripps Research Institute
-
Nigel Calcutt, Ph.D.
- Professor, University of California, San Diego
- Co-Founder, WinSanTor
-
Allen Downs, CLP
- Senior Corporate & Business Development Lead, Corporate & Business Development
- Mundipharma International Limited
-
Andre Ghetti, Ph.D.
- Chief Executive Officer
- AnaBios Corporation
-
Narender Gavva, Ph.D.
- Scientific Director
- Amgen
-
Geert Jan Groeneveld, MD, Ph.D.
- Research Director, CNS
- Centre for Human Drug Research
-
Tilo Grosser, MD
- Research Associate Professor, Department of Systems Pharmacology and Translational Therapeutics, Institute for Translational Medicine and Therapeutics, Perelman School of Medicine
- University of Pennsylvania
-
Mary Hannaman, MD
- President, Co-Founder
- NeuroDigm
-
Sunyoung Kim, D.Phil.
- Founder and Chief Scientific Officer
- Viromed
-
D. Lynn Kirkpatrick, Ph.D.
- President and CEO
- Ensysce Biosciences
-
Sanford J. Madigan, Ph.D.
- Chief Executive Officer
- Sova Pharmaceuticals
-
Aashish Manglik, MD, Ph.D.
- Stanford Distinguished Fellow, Department of Molecular and Cellular Physiology
- Stanford University School of Medicine
-
Daniel Mikol, MD, Ph.D.
- Executive Medical Director, Global Neuroscience Development
- Amgen
-
Mikhail "Mike" Nemenov, Ph.D.
- Founder and Chief Scientist, LasMed LLC
- Senior Research Scholar, Stanford University
-
Frank Rice, Ph.D.
- President and Chief Scientist
- Integrated Tissue Dynamics
-
Neil Singla, MD
- Chief Scientific Officer
- Lotus Clinical Research
-
Randall Stevens, MD
- Chief Medical Officer
- Centrexion Therapeutics
-
Simon Tate, Ph.D.
- Chief Scientific Officer, Convergence Pharmaceuticals
- Non-Executive Director, Biogen
-
Tanya Wallace, Ph.D.
- Head of Biology
- Blackthorn Therapeutics
-
Eric Nisenbaum, Ph.D.
- Group Leader Neurophysiology, Neuroscience Division
- Eli Lilly and Company
